News

Lupus is a chronic autoimmune disease that can cause widespread inflammation and affect many parts of the body, including the ...
Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.
May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.
The cell and gene therapy company is cutting 47 employees and its entire lupus program to focus resources on two CAR Ts. The ...
Cutaneous lupus affects quality of life by limiting social participation and increasing mental health concerns, according to ...
Join Drs Maureen McMahon and Michael Garshick as they discuss cardiovascular disease in patients with systemic lupus erythematosus, focusing on hidden risk and challenging clinical scenarios.
The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...
The Lupus Research Alliance (LRA) is proud to announce the recipients of this year's Lupus Innovation Award (LIA), addressing ...